Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.75)
# 1,912
Out of 4,876 analysts
27
Total ratings
58.33%
Success rate
17.19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $10.88 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $284.27 | +21.01% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $13.49 | +296.59% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $36.72 | +8.93% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.10 | +129.01% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $3.69 | +130.35% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $9.20 | +73.91% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.90 | +36,831.03% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.16 | +14,275.00% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.29 | +1,450.15% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.10 | +125.35% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $2.88 | +1,462.50% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.88
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $284.27
Upside: +21.01%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $13.49
Upside: +296.59%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $36.72
Upside: +8.93%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.10
Upside: +129.01%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $3.69
Upside: +130.35%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $9.20
Upside: +73.91%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.90
Upside: +36,831.03%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.16
Upside: +14,275.00%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.29
Upside: +1,450.15%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $7.10
Upside: +125.35%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $2.88
Upside: +1,462.50%